State PA
Clinical Trials in Pennsylvania
Pennsylvania is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Pennsylvania and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 478 actively recruiting studies with Pennsylvania sites out of 478 registered in total. The busiest research areas in Pennsylvania are Prostate Cancer, Ovarian Cancer, Breast Cancer. Leading sponsors running trials in the state include University of Pennsylvania, University of Pittsburgh, Abramson Cancer Center at Penn Medicine. By stage, Pennsylvania trials break down as Phase 1 (82), Phase 2 (138), Phase 3 (101), Phase 4 (17).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Pennsylvania
Frequently Asked Questions — Clinical Trials in Pennsylvania
How many clinical trials are currently recruiting in Pennsylvania?
ClinicalMetric currently tracks 478 actively recruiting clinical trials with at least one location in Pennsylvania. The total number of registered studies—including active but not currently enrolling trials—is 478. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Pennsylvania?
Pennsylvania hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Ovarian Cancer, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Pennsylvania serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Pennsylvania?
To join a clinical trial in Pennsylvania, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Pennsylvania maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Pennsylvania
NCT07124000 N/A
Recruiting
DESTINY-PANTUMOUR04
Condition
Adenocarcinoma (NOS)
Enrollment
100 pts
Location
United States
Sponsor
AstraZeneca
NCT06127199 N/A
Recruiting
Contraceptive Efficacy Study of Ovaprene
Condition
Contraception
Enrollment
656 pts
Location
United States
Sponsor
Daré Bioscience, Inc.
NCT07002034 Phase 2
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medic...
Condition
Adjustment Disorder
Enrollment
100 pts
Location
United States
Sponsor
Reunion Neuroscience Inc
NCT01401998 N/A
Recruiting
ARPKD Database Study
Condition
Hepato/Renal Fibrocystic Disease
Enrollment
200 pts
Location
United States
Sponsor
Children's Hospital of Philade
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07523581 Phase 2
Recruiting
EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exalur...
Condition
Alport Syndrome, X-Linked
Enrollment
24 pts
Location
United States, United Kingdom
Sponsor
Eloxx Pharmaceuticals, Inc.
NCT05967507 N/A
Recruiting
Laryngoscopy for Neonatal and Infant Airway Management wIth Supplemental Oxygen ...
Condition
Airway Management
Enrollment
1,192 pts
Location
United States, Australia, Brazil
Sponsor
Thomas Riva
NCT06121011 N/A
Recruiting
A Global Prospective Observational Registry of Patients With Pompe Disease
Condition
Pompe Disease
Enrollment
500 pts
Location
United States, Austria, Belgium
Sponsor
Amicus Therapeutics
NCT06457919 Phase 1, Phase 2
Recruiting
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in Pe...
Condition
Prostate Cancer
Enrollment
50 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06241456 Phase 1
Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibod...
Condition
Advanced Solid Tumor
Enrollment
351 pts
Location
United States
Sponsor
Fate Therapeutics
NCT06087029 N/A
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Condition
Type B Aortic Dissection
Enrollment
1,100 pts
Location
United States, Canada
Sponsor
Duke University
NCT07266831 Phase 2, Phase 3
Recruiting
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have No...
Condition
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Enrollment
570 pts
Location
United States, Argentina, Canada
Sponsor
Merck Sharp & Dohme LLC
NCT03797495 N/A
Recruiting
Study of Individuals Affected With Hypoplasminogenemia
Condition
Plasminogen Deficiency
Enrollment
100 pts
Location
United States, Argentina, Australia
Sponsor
Indiana Hemophilia &Thrombosis
NCT05885412 Phase 1
Recruiting
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediat...
Condition
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Enrollment
9 pts
Location
United States
Sponsor
Rocket Pharmaceuticals Inc.
NCT07061951 Phase 2
Recruiting
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Rel...
Condition
Recurrent Chronic Lymphocytic Leukemia
Enrollment
20 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05446272 N/A
Recruiting
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
Condition
Extubation Failure
Enrollment
478 pts
Location
United States, Canada
Sponsor
University of Pennsylvania
NCT06263231 Phase 3
Recruiting
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US...
Condition
Sarcoma,Soft Tissue
Enrollment
333 pts
Location
United States, Canada, France
Sponsor
Intensity Therapeutics, Inc.
NCT06826859 Phase 1, Phase 2
Recruiting
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
Condition
Preterm Birth
Enrollment
400 pts
Location
United States
Sponsor
Thomas Jefferson University
NCT05490888 Phase 1
Recruiting
Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirr...
Condition
Cirrhosis, Liver
Enrollment
74 pts
Location
United States
Sponsor
PharmaIN
NCT05867251 Phase 1, Phase 2
Recruiting
Study of AVZO-021 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
430 pts
Location
United States, Australia
Sponsor
Avenzo Therapeutics, Inc.
NCT04429542 Phase 1
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therap...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
473 pts
Location
United States, Australia, Canada
Sponsor
Bicara Therapeutics
NCT06095505 Phase 2
Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Condition
Small Cell Lung Cancer
Enrollment
120 pts
Location
United States
Sponsor
Puma Biotechnology, Inc.
NCT05654922 Phase 3
Recruiting
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progress...
Condition
Pre-Bronchiolitis Obliterans Syndrome
Enrollment
100 pts
Location
United States
Sponsor
Renovion, Inc.
NCT07067788 N/A
Recruiting
B.Brilliant Revelation Comparision Study
Condition
Breast Cancer Screening
Enrollment
100 pts
Location
United States
Sponsor
University of Pennsylvania
NCT07300969 Phase 2
Recruiting
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Condition
Major Depressive Disorder (MDD)
Enrollment
300 pts
Location
United States, Bulgaria, Czechia
Sponsor
Draig Therapeutics Ltd
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology